WKC

5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]-3-[4-(piperidin-4-yl)anilino]pyrazine-2-carboxamide

Created:	2022-09-19
Last modified:	2023-02-15

Find Related PDB Entry
1 entries where WKC is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	69
Chiral Atom Count	1
Bond Count	73
Aromatic Bond Count	12

2D diagram of WKC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-[(3R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl]-3-[4-(piperidin-4-yl)anilino]pyrazine-2-carboxamide
Systematic Name (OpenEye OEToolkits)	5-[(3~{R})-3-(3-methyl-2-oxidanylidene-imidazolidin-1-yl)piperidin-1-yl]-3-[(4-piperidin-4-ylphenyl)amino]pyrazine-2-carboxamide
Formula	C₂₅ H₃₄ N₈ O₂
Molecular Weight	478.59
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	NC(=O)c1ncc(nc1Nc1ccc(cc1)C1CCNCC1)N1CCCC(C1)N1CCN(C)C1=O
SMILES	CACTVS	3.385	CN1CCN([CH]2CCCN(C2)c3cnc(C(N)=O)c(Nc4ccc(cc4)C5CCNCC5)n3)C1=O
SMILES	OpenEye OEToolkits	2.0.7	CN1CCN(C1=O)C2CCCN(C2)c3cnc(c(n3)Nc4ccc(cc4)C5CCNCC5)C(=O)N
Canonical SMILES	CACTVS	3.385	CN1CCN([C@@H]2CCCN(C2)c3cnc(C(N)=O)c(Nc4ccc(cc4)C5CCNCC5)n3)C1=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1CCN(C1=O)[C@@H]2CCCN(C2)c3cnc(c(n3)Nc4ccc(cc4)C5CCNCC5)C(=O)N
InChI	InChI	1.06	InChI=1S/C25H34N8O2/c1-31-13-14-33(25(31)35)20-3-2-12-32(16-20)21-15-28-22(23(26)34)24(30-21)29-19-6-4-17(5-7-19)18-8-10-27-11-9-18/h4-7,15,18,20,27H,2-3,8-14,16H2,1H3,(H2,26,34)(H,29,30)/t20-/m1/s1
InChIKey	InChI	1.06	JCGXVYWABUYORV-HXUWFJFHSA-N

Related Resource References

Resource Name	Reference
PubChem	118114824

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.